Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-04-14 @ 8:03 PM
Study NCT ID:
NCT00473135
Status:
COMPLETED
Last Update Posted:
2010-01-13
First Post:
2007-05-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CIR 229
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Anna Durbin, MD
Old Organization:
Center for Immunization Research, Johns Hopkins School of Public Health
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |